Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells

Millie Hughes-Fulford, Raymond R. Tjandrawinata, Chai-Fei Li, Sina Sayyah

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

For the past 60 years, dietary intake of essential fatty acids has increased. Moreover, the omega-6 fatty acids have recently been found to play an important role in regulation of gene expression. Proliferation of human prostate cells was significantly increased 48 h after arachidonic acid (AA) addition. We have analyzed initial uptake using nile red fluorescence and we found that the albumin conjugated AA is endocytosed into the cells followed by the induction of RNA within minutes, protein and PGE2 synthesis within hours. Here we describe that AA induces expression of cytosolic phospholipase A2 (cPLA2) in a dose-dependent manner and that this upregulation is dependent upon downstream synthesis of PGE2. The upregulation of cox-2 and cPLA2 was inhibited by flurbiprofen, a cyclooxygenase (COX) inhibitor, making this a second feed-forward enzyme in the eicosanoid pathway. Cox-2 specific inhibitors are known to inhibit colon and prostate cancer growth in humans; however, recent findings show that some of these have cardiovascular complications. Since cPLA2 is upstream in the eicosanoid pathway, it may be a good alternative for a pharmaceautical target for the treatment of cancer.

Original languageEnglish (US)
Pages (from-to)1520-1526
Number of pages7
JournalCarcinogenesis
Volume26
Issue number9
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Omega-6 Fatty Acids
Cytosolic Phospholipases A2
Phospholipases A2
Arachidonic Acid
Prostate
Eicosanoids
Carcinoma
Dinoprostone
Up-Regulation
Flurbiprofen
Essential Fatty Acids
Cyclooxygenase Inhibitors
Gene Expression Regulation
Endocytosis
Colonic Neoplasms
Albumins
Prostatic Neoplasms
Fluorescence
RNA
Enzymes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. / Hughes-Fulford, Millie; Tjandrawinata, Raymond R.; Li, Chai-Fei; Sayyah, Sina.

In: Carcinogenesis, Vol. 26, No. 9, 01.09.2005, p. 1520-1526.

Research output: Contribution to journalArticle

Hughes-Fulford, Millie ; Tjandrawinata, Raymond R. ; Li, Chai-Fei ; Sayyah, Sina. / Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. In: Carcinogenesis. 2005 ; Vol. 26, No. 9. pp. 1520-1526.
@article{29048601973a4c39ad23b6539fc9c609,
title = "Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells",
abstract = "For the past 60 years, dietary intake of essential fatty acids has increased. Moreover, the omega-6 fatty acids have recently been found to play an important role in regulation of gene expression. Proliferation of human prostate cells was significantly increased 48 h after arachidonic acid (AA) addition. We have analyzed initial uptake using nile red fluorescence and we found that the albumin conjugated AA is endocytosed into the cells followed by the induction of RNA within minutes, protein and PGE2 synthesis within hours. Here we describe that AA induces expression of cytosolic phospholipase A2 (cPLA2) in a dose-dependent manner and that this upregulation is dependent upon downstream synthesis of PGE2. The upregulation of cox-2 and cPLA2 was inhibited by flurbiprofen, a cyclooxygenase (COX) inhibitor, making this a second feed-forward enzyme in the eicosanoid pathway. Cox-2 specific inhibitors are known to inhibit colon and prostate cancer growth in humans; however, recent findings show that some of these have cardiovascular complications. Since cPLA2 is upstream in the eicosanoid pathway, it may be a good alternative for a pharmaceautical target for the treatment of cancer.",
author = "Millie Hughes-Fulford and Tjandrawinata, {Raymond R.} and Chai-Fei Li and Sina Sayyah",
year = "2005",
month = "9",
day = "1",
doi = "10.1093/carcin/bgi112",
language = "English (US)",
volume = "26",
pages = "1520--1526",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells

AU - Hughes-Fulford, Millie

AU - Tjandrawinata, Raymond R.

AU - Li, Chai-Fei

AU - Sayyah, Sina

PY - 2005/9/1

Y1 - 2005/9/1

N2 - For the past 60 years, dietary intake of essential fatty acids has increased. Moreover, the omega-6 fatty acids have recently been found to play an important role in regulation of gene expression. Proliferation of human prostate cells was significantly increased 48 h after arachidonic acid (AA) addition. We have analyzed initial uptake using nile red fluorescence and we found that the albumin conjugated AA is endocytosed into the cells followed by the induction of RNA within minutes, protein and PGE2 synthesis within hours. Here we describe that AA induces expression of cytosolic phospholipase A2 (cPLA2) in a dose-dependent manner and that this upregulation is dependent upon downstream synthesis of PGE2. The upregulation of cox-2 and cPLA2 was inhibited by flurbiprofen, a cyclooxygenase (COX) inhibitor, making this a second feed-forward enzyme in the eicosanoid pathway. Cox-2 specific inhibitors are known to inhibit colon and prostate cancer growth in humans; however, recent findings show that some of these have cardiovascular complications. Since cPLA2 is upstream in the eicosanoid pathway, it may be a good alternative for a pharmaceautical target for the treatment of cancer.

AB - For the past 60 years, dietary intake of essential fatty acids has increased. Moreover, the omega-6 fatty acids have recently been found to play an important role in regulation of gene expression. Proliferation of human prostate cells was significantly increased 48 h after arachidonic acid (AA) addition. We have analyzed initial uptake using nile red fluorescence and we found that the albumin conjugated AA is endocytosed into the cells followed by the induction of RNA within minutes, protein and PGE2 synthesis within hours. Here we describe that AA induces expression of cytosolic phospholipase A2 (cPLA2) in a dose-dependent manner and that this upregulation is dependent upon downstream synthesis of PGE2. The upregulation of cox-2 and cPLA2 was inhibited by flurbiprofen, a cyclooxygenase (COX) inhibitor, making this a second feed-forward enzyme in the eicosanoid pathway. Cox-2 specific inhibitors are known to inhibit colon and prostate cancer growth in humans; however, recent findings show that some of these have cardiovascular complications. Since cPLA2 is upstream in the eicosanoid pathway, it may be a good alternative for a pharmaceautical target for the treatment of cancer.

UR - http://www.scopus.com/inward/record.url?scp=24144488379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144488379&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgi112

DO - 10.1093/carcin/bgi112

M3 - Article

C2 - 15878913

AN - SCOPUS:24144488379

VL - 26

SP - 1520

EP - 1526

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -